USC Focuses on Prevention as They Develop Alzheimer's Vaccine
Research on the right track
Quoting Schneider, “If we can delay the onset of Alzheimer’s by five years, for example, the incidence of the illness would drop by half. It would also give individuals five more years without symptoms of the illness.”
Scientists are aiming to show that either the vaccine or the oral medication is capable of delaying the disease among high-risk people. When this happens, it can strongly imply that the study is on the right track as they develop treatments for Alzheimer’s.